DANILOVSKI; Aleksandar

Patent Applications and Registrations

Patent applications and USPTO patent grants for DANILOVSKI; Aleksandar.The latest application filed is for "pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate".

Company Profile

0.8.16

DANILOVSKI; Aleksandar - Rijeka HR
Danilovski; Aleksandar - Zagreb HR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutically Acceptable Salt And Polymorphic Forms Of Flupirtine Maleate App 20120142743 - DANILOVSKI; Aleksandar ; et al.	2012-06-07
Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate Grant 8,138,349 - Danilovski , et al. March 20, 2	2012-03-20
Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate App 20110184030 - Danilovski; Aleksandar ; et al.	2011-07-28
Single dose fast dissolving azithromycin Grant 7,572,773 - Danilovski , et al. August 11, 2	2009-08-11
Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A Grant 7,569,549 - Dumic , et al. August 4, 2	2009-08-04
Pharmaceutically Acceptable Salts And Polymorphic Forms App 20090137613 - Ceric; Helena ; et al.	2009-05-28
Crystal modification of torasemide App 20070276015 - Filic; Darko ; et al.	2007-11-29
Novel Polymorph V of Torasemide App 20070238759 - Filic; Darko ; et al.	2007-10-11
Polymorph V of torasemide Grant 7,241,782 - July 10, 2	2007-07-10
New crystal modification of torasemide App 20060205951 - Filic; Darko ; et al.	2006-09-14
Process for the preparation of modification I of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonam- ide App 20060100439 - Filic; Darko ; et al.	2006-05-11
Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamid- e and cyclic oligosaccharides Grant 7,037,928 - Dumic , et al. May 2, 2	2006-05-02
Amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A, process for preparing the same, and uses thereof Grant 6,936,591 - Dumic , et al. August 30, 2	2005-08-30
Solid-state form of alendronate sodium and preparation thereof App 20050113343 - Sienkiewicz, Barbara ; et al.	2005-05-26
Single dose fast dissolving azithromycin App 20050026851 - Danilovski, Aleksandar ; et al.	2005-02-03
Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-m- ethyl) sulfinyl]-1H-benzimidazole sodium aquo complexes App 20050004172 - Filic, Darko ; et al.	2005-01-06
Crystal modification of torasemide Grant 6,833,379 - Filic , et al. December 21, 2	2004-12-21
Crystal modification of torasemide App 20040229919 - Filic, Darko ; et al.	2004-11-18
Amorphous torasemide modification Grant 6,767,917 - Filic , et al. July 27, 2	2004-07-27
Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A, process for preparing the same, and uses thereof App 20040092460 - Dumic, Miljenko ; et al.	2004-05-13
Compositions of n-(methylethaylaminocarbonyl)-4-(-3-methylphenylamino)-3-p- yridylsulfonamide and cyclic oligosacccharides App 20040039204 - Dumic, Miljenko ; et al.	2004-02-26
Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythrom- ycin A App 20040014951 - Dumic, Miljenko ; et al.	2004-01-22
New Crystal Modification Of Torasemide App 20030055258 - Filic , Darko ; et al.	2003-03-20
New crystal modification of torasemide App 20020147346 - Filic, Darko ; et al.	2002-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.